文献速递肾移植

肾移植受者使用利尿剂与长期移植后糖尿病风险增加相关

Association of diuretic use with increased risk for long-term post-transplantation diabetes mellitus in kidney transplant recipients.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

该前瞻性队列纳入486例无糖尿病的稳定门诊肾移植受者,按病历核实分为利尿剂使用者168例与非使用者318例。中位随访5.2年后54例(11%)发生移植后糖尿病;校正年龄、性别、空腹血糖和HbA1c后,利尿剂使用与移植后糖尿病风险增加相关(HR 3.28,95%CI 1.84–5.83,P<0.001),噻嗪类和袢利尿剂均显示关联。

要点

  • 利尿剂使用者移植后糖尿病风险升高(HR 3.28,95%CI 1.84–5.83,P<0.001)。
  • 噻嗪类利尿剂HR 2.70(95%CI 1.24–5.29,P=0.012)。
  • 袢利尿剂HR 5.08(95%CI 2.49–10.34,P<0.001)。

核心结论

  • 利尿剂整体与肾移植受者发生移植后糖尿病风险增加相关,且独立于已知的移植后糖尿病危险因素。
  • 噻嗪类和袢利尿剂均显示与移植后糖尿病发生的关联。

研究设计与样本

  • 前瞻性队列研究,纳入486例移植肾功能稳定≥1年、无糖尿病的稳定门诊肾移植受者。
  • 根据病历核实的用药情况将参与者分为利尿剂使用者168例(35%)和非使用者318例。

主要发现

  • 基线时168例(35%)使用利尿剂(噻嗪类n=74;袢利尿剂n=76;其他n=18),318例未使用利尿剂。
  • 随访5.2年(四分位距4.0–5.9年)后,54例(11%)发生移植后糖尿病。
  • Cox回归分析中,校正年龄、性别、空腹血糖和HbA1c后,利尿剂使用与移植后糖尿病发生相关(HR 3.28,95%CI 1.84–5.83,P<0.001)。
  • 进一步校正生活方式、心血管疾病家族史、其他用药、肾功能、移植相关参数、BMI、血脂和血压等潜在混杂因素后,该关联无实质性改变。
  • 校正年龄、性别、空腹血糖和HbA1c后,噻嗪类利尿剂(HR 2.70,95%CI 1.24–5.29,P=0.012)和袢利尿剂(HR 5.08,95%CI 2.49–10.34,P<0.001)均与移植后糖尿病发生相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-transplantation diabetes mellitus (PTDM) is a major clinical problem in kidney transplant recipients (KTRs). Diuretic-induced hyperglycaemia and diabetes have been described in the general population. We aimed to investigate whether diuretics also increase PTDM risk in KTRs. METHODS: We included 486 stable outpatient KTRs (with a functioning graft ≥1 year) without diabetes from a prospective cohort study. Participants were classified as diuretic users and non-users based on their medication use verified by medical records. RESULTS: At the baseline study, 168 (35%) KTRs used a diuretic (thiazide, n = 74; loop diuretic, n = 76; others, n = 18) and 318 KTRs did not use a diuretic. After 5.2 years [interquartile range (IQR) 4.0‒5.9] of follow up, 54 (11%) KTRs developed PTDM. In Cox regression analyses, diuretic use was associated with incident PTDM, independent of age, sex, fasting plasma glucose (FPG) and haemoglobin A1c (HbA1c) {hazard ratio [HR] 3.28 [95% confidence interval (CI) 1.84-5.83]; P <0.001}. Further adjustment for potential confounders, including lifestyle, family history of cardiovascular disease, use of other medication, kidney function, transplantation-specific parameters, BMI, lipids and blood pressure did not materially change the association. Moreover, in Cox regression analyses, both thiazide and loop diuretics associated with the development of PTDM, independent of age, sex, FPG and HbA1c [HR 2.70 (95% CI 1.24-5.29); P = 0.012 and HR 5.08 (95% CI 2.49-10.34); P <0.001), respectively]. CONCLUSIONS: This study demonstrates that diuretics overall are associated with an increased risk of developing PTDM in KTRs, independent of established risk factors for PTDM development. The association was present for both thiazide and loop diuretics.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Sokooti S, Klont F, Tye SC, et al. Association of diuretic use with increased risk for long-term post-transplantation diabetes mellitus in kidney transplant recipients. Nephrol Dial Transplant. 2022. PMID: 35092430. doi:10.1093/ndt/gfac012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。